US rheumatoid arthritis market to reach $9.3 bn by 2020'

Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 02 Apr, 2015

Singapore: US treatment market for rheumatoid arthritis (RA) is set to increase in value from $6.4 billion in 2013 to $9...Read more

BioSpectrum announces the hits and misses of 2013

Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 02 Jan, 2014

Asia attracted a lot of interest from foreign multinational giants in the year 2013. This not only led to the increase i...Read more

Teva proposes to buy Mylan for $40.1 billion

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 22 Apr, 2015

Singapore: Israeli generic drug giant Teva pharmaceuticals made an unsolicited offer to buy US-based Mylan NV for about ...Read more

Teva's Potential $40 bn Mylan acquisition could transform generics space'

Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 27 Apr, 2015

Singapore: Teva Pharmaceutical Industries' recent $40.1 billion offer to purchase Netherlands-based Mylan, which is cruc...Read more

TB claims 74000 children each year: WHO

Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 02 Oct, 2013

Singapore: World Health Organization has launched "Roadmap for childhood TB: towards zero deaths", in an effort to preve...Read more

Boehringer, Lilly diabetes drug shows +ve results

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jun, 2013

Singapore: Boehringer Ingelheim and Eli Lilly and Company have presented their results from two randomized phase III cli...Read more

Indian drugmakers shifting R&D to South East Asia

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jul, 2013

Singapore: Many leading Indian drug makers, that comprise a core part of the country's $1,000 bn worth pharmaceutical in...Read more

Unlike FDA, Indian regulators finds no violations at Ranbaxy

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 20 Sep, 2013

Singapore: India's Drugs Controller General of India (DCGI) has said that under the country's Drugs and Cosmetics Act, i...Read more

Pfizer, Hisun launch generics joint venture in China

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 13 Sep, 2012

Singapore: Pfizer and China's Zhejiang Hisun Pharmaceuticals, a leading Chinese pharmaceutical company, announced the la...Read more

Teva launches generic of Abilify, antipsychotic drug

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 30 Apr, 2015

Singapore: Teva Pharmaceutical has launched the generic equivalent to Abilify, aripiprazole tablets, an atypical antipsy...Read more

Sun's generic of Takeda ulcer drug gets FDA nod

Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 16 Sep, 2013

Singapore: Indian pharmaceutical major, Sun Pharmaceutical Industries announced that the generic version of Prevacid by ...Read more

Teva to pay $718 mn to apex tax body in Israel

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 13 Nov, 2013

Singapore: Israel-based Teva Pharmaceutical is going to pay $718 million to Israel Tax Authority to pay for the release ...Read more

Sandoz gets FDA nod for MS generic drug

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 17 Apr, 2015

Singapore: Sandoz, a Novartis company, has recieved USFDA approval of Glatopa, a first generic version of Teva's Copaxon...Read more

Drug shortage forces FDA to approve cancer generic

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 06 Nov, 2013

Singapore: The US FDA has provided its approval for a generic version of cancer drug Doxil that has been facing shortage...Read more

Hong Kong to host international TCM exhibition, conference

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 12 Aug, 2013

Singapore: Hong Kong Trade Development Council (HKTDC) and Modernized Chinese Medicine International Association (MCMIA ...Read more

Britain's MHRA recalls 16 Wockhardt medicines

Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 12 Jul, 2013

Singapore: UK's drug regulatory body, Medicines and Healthcare products Regulatory Agency (MHRA) has recalled 16 drugs m...Read more

Chinese planning agency to probe pharma prices

Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 05 Jul, 2013

Singapore: China's primary economic planning agency, the National Development and Reform Commission (NDRC) is in the pro...Read more

Aurobindo recalls epilepsy drug lot in US

Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 25 Nov, 2014

Singapore: India-based Aurobindo Pharma in the US is recalling Gabapentin capsules, USP 300 mg 100-count bottles, at con...Read more